1. The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
   Irene Vanni et al, 2020, Frontiers in Molecular Biosciences CrossRef
2. Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets
   Elena-Georgiana Dobre et al, 2022, Journal of Personalized Medicine CrossRef
3. Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
   Leila Jahangiri et al, 2019, Cancers CrossRef
4. Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
   Guillaume Herbreteau et al, 2021, Cancers CrossRef
5. The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
   Elizabeth L. Thompson et al, 2021, Cancers CrossRef
6. Evaluating the Diagnostic Potentials of Circulating Tumor DNA against Melanoma: A Systematic Review and Meta-Analysis
   Jianchao Zhang et al, 2022, Journal of Oncology CrossRef